drugset / Trial / NCT00002349

A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.

NCT00002349

Completed 40 enrolled Bristol-Myers Squibb
RandomizedSingle-groupDouble-blindTreatment

Summary

To compare the antiviral effect of stavudine ( d4T ) versus placebo in patients with evidence of recent HIV infection. Also, to compare the immunologic effects and effects on quality of life of d4T in these patients.

Timeline

Start
1995-01
Primary completion
1999-05
Completion
1999-05

Publications

  • Background Katlama C, Molina JM, Rozenbaum W, Valantin MA, Modai J, Chauveau E, Ngo Van P, Gres JJ. Stavudine ( D4T ) in HIV infected patients with CD4 less than 350/mm3: results of a double-blind randomized placebo controlled study. Conf Retroviruses Opportunistic Infect. 1996 Jan 28-Feb 1;3rd:89

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified